Extrapolation of Midazolam Disposition in Neonates Using Physiological-Based Pharmacokinetic/Pharmacodynamic...

Area of Science:

• Pharmacology
• Neonatal Medicine
• Computational Biology

Background:

• Limited clinical data in neonatal populations necessitates advanced modeling techniques.
• Extrapolation strategies and simulations are crucial for pediatric drug development.
• Physiological-based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling offers a robust approach.

Purpose of the Study:

• To establish and validate a neonatal PBPK/PD model for drug dosage simulation.
• To optimize midazolam dosage regimens for neonatal sedation.
• To assess the utility of pediatric extrapolation strategies in neonatal drug development.

Main Methods:

• An adult PBPK/PD model was adapted for neonates using maturation formulas.
• Pediatric extrapolation strategies were employed for model extension.
• Midazolam dosage regimens were simulated and validated against existing data.

Main Results:

• The adult model achieved high prediction accuracy (95.1% within 2-fold).
• The extrapolated neonatal model demonstrated good performance (84.4% within 2-fold, AAFE <2).
• Simulations suggested optimal midazolam dosing for term neonates and potential adjustments for premature infants.

Conclusions:

• The validated neonatal PBPK/PD model is adequate for predicting drug concentrations.
• This extrapolation and simulation strategy effectively supports neonatal drug dose prediction and optimization.
• Findings provide a framework for improving medication safety and efficacy in neonates.